Avidity Partners Management LP
Filing Date
Global Rank
#2,402
/ 8,603
▲ 689
· as of Mar 2026
Top Industry
Biotechnology
81.0%
3Y Alpha vs SPY
+7.0%
Period ended 3 months ago
Filed May 28, 2026 · 42d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+86.7%
SPY
+76.5%
Annualised alpha
+2.3%
Max drawdown
−38.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
52 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
30.2%
+7.3 pts
Top 5
68.5%
+11.9 pts
Top 10
81.8%
+10.9 pts
HHI
1,408
Diversified+438
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.4% | $581,052,027 |
| Consumer Defensive | 0.5% | $2,660,600 |
| Consumer Cyclical | 0.1% | $858,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | +2,839,266 | 6,049,999 | $25,228,495 | |
| IMUX | Immunic, Inc. | +2,000,000 | 6,699,411 | $74,363,462 | |
| KPTI | Karyopharm Therapeutics Inc. | +329,175 | 463,741 | $2,583,037 | |
| ELVN | Enliven Therapeutics, Inc. | +259,700 | 400,000 | $15,680,000 | |
| ORKA | Oruka Therapeutics, Inc. | +100,000 | 760,424 | $37,298,797 | |
| PVLA | Palvella Therapeutics, Inc. | +50,700 | 70,000 | $8,725,500 | |
| PHAT | Phathom Pharmaceuticals, Inc. | +43,314 | 249,390 | $2,770,722 | |
| TEVA | Teva Pharmaceutical Industries Ltd | +32,800 | 450,100 | $13,557,012 | |
| RGEN | Repligen Corp | +27,500 | 77,800 | $9,166,396 | |
| EHC | Encompass Health Corp | +10,400 | 42,000 | $4,062,660 | |
| CORT | Corcept Therapeutics Inc | +8,000 | 30,000 | $1,209,300 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
10 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CNTX | Context Therapeutics Inc. | −506,588 | 4,998,267 | $13,095,459 | |
| CGON | CG Oncology, Inc. | −183,751 | 1,288,948 | $87,236,000 | |
| KVUE | Kenvue Inc. | −132,800 | 100,000 | $1,724,000 | |
| ACAD | Acadia Pharmaceuticals Inc | −93,933 | 12,967 | $288,645 | |
| BSX | Boston Scientific Corp | −54,500 | 60,000 | $3,765,000 | |
| CNC | Centene Corp | −49,400 | 70,000 | $2,291,800 | |
| GMAB | Genmab A/S | −42,000 | 50,000 | $1,341,500 | |
| ICLR | Icon PLC | −17,100 | 16,000 | $1,770,560 | |
| MDT | Medtronic plc | −7,600 | 100,000 | $8,665,000 | |
| NTRA | Natera, Inc. | −2,800 | 9,000 | $1,799,910 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | 950,000 | $8,512,000 | |
| AKTS | Aktis Oncology, Inc. | 468,566 | $8,382,645 | |
| DXCM | Dexcom Inc | 90,000 | $5,652,000 | |
| HUM | Humana Inc | 25,000 | $4,334,750 | |
| TENX | Tenax Therapeutics, Inc. | 215,934 | $3,452,784 | |
| GILD | Gilead Sciences, Inc. | 20,000 | $2,787,400 | |
| MSLE | Satellos Bioscience Inc. | 387,769 | $2,183,139 | |
| PODD | Insulet Corp | 10,000 | $2,098,400 | |
| CRL | Charles River Laboratories International, Inc. | 10,000 | $1,725,000 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 115,000 | $1,682,450 | |
| HIMS | Hims & Hers Health, Inc. | 75,000 | $1,557,000 | |
| RVMD | Revolution Medicines, Inc. | 15,000 | $1,458,750 | |
| GPCR | Structure Therapeutics Inc. | 30,000 | $1,446,000 | |
| TEM | Tempus AI, Inc. | 25,000 | $1,130,500 | |
| ABVX | Abivax S.A. | 10,000 | $1,113,500 | |
| UNH | Unitedhealth Group Inc | 3,800 | $1,028,242 | |
| ABT | Abbott Laboratories | 10,000 | $1,026,700 | |
| NTLA | Intellia Therapeutics, Inc. | 75,000 | $961,500 | |
| ODD | Oddity Tech Ltd | 70,000 | $936,600 | |
| MLTX | MoonLake Immunotherapeutics | 50,000 | $932,000 | |
| PTON | Peloton Interactive, Inc. | 200,000 | $858,000 | |
| AVR | Anteris Technologies Global Corp. | 150,000 | $832,500 | |
| BBIO | BridgeBio Pharma, Inc. | 10,000 | $742,600 | |
| ABUS | Arbutus Biopharma Corp | 125,000 | $562,500 | |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 43,853 | $392,484 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
15 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals, Inc. | 21,000 | $8,350,650 | |
| MCK | Mckesson Corp | 9,520 | $7,809,160 | |
| A | Agilent Technologies, Inc. | 41,500 | $5,646,905 | |
| PFE | Pfizer Inc | 203,600 | $5,069,640 | |
| DHR | Danaher Corp /De/ | 17,000 | $3,891,640 | |
| TMO | Thermo Fisher Scientific Inc. | 6,700 | $3,882,315 | |
| NVO | Novo Nordisk A S | 67,300 | $3,424,224 | |
| CI | Cigna Group | 11,600 | $3,192,668 | |
| COR | Cencora, Inc. | 9,400 | $3,174,850 | |
| INSM | INSMED Inc | 17,700 | $3,080,508 | |
| WAT | Waters Corp /De/ | 8,100 | $3,076,623 | |
| ACHC | Acadia Healthcare Company, Inc. | 169,000 | $2,398,110 | |
| ITGR | Integer Holdings Corp | 29,800 | $2,337,214 | |
| HQY | Healthequity, Inc. | 16,900 | $1,548,209 | |
| IQV | Iqvia Holdings Inc. | 4,400 | $991,804 | |
| No positions match the current search. | ||||
52 positions ·
$584,570,627 total
· as of Mar 31, 2026
Showing 1–50
of 52 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Held | 2,104,184 | $176,583,121 | 30.21% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
Reduced | 1,288,948 | $87,236,000 | 14.92% | |
| IMUX |
Immunic, Inc.
Healthcare
|
Added | 6,699,411 | $74,363,462 | 12.72% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Added | 760,424 | $37,298,797 | 6.38% | |
| CATX |
Perspective Therapeutics, Inc.
Healthcare
|
Added | 6,049,999 | $25,228,495 | 4.32% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Held | 1,400,708 | $19,679,947 | 3.37% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Added | 400,000 | $15,680,000 | 2.68% | |
| SCYX |
Scynexis Inc
Healthcare
|
Reduced | 2,081,660 | $15,271,057 | 2.61% | |
| TEVA |
Teva Pharmaceutical Industries Ltd
Healthcare
|
Added | 450,100 | $13,557,012 | 2.32% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
Reduced | 4,998,267 | $13,095,459 | 2.24% | |
| RGEN |
Repligen Corp
Healthcare
|
Added | 77,800 | $9,166,396 | 1.57% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Added | 70,000 | $8,725,500 | 1.49% | |
| MDT |
Medtronic plc
Healthcare
|
Reduced | 100,000 | $8,665,000 | 1.48% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
NEW | 950,000 | $8,512,000 | 1.46% | |
| AKTS |
Aktis Oncology, Inc.
Healthcare
|
NEW | 468,566 | $8,382,645 | 1.43% | |
| DXCM |
Dexcom Inc
Healthcare
|
NEW | 90,000 | $5,652,000 | 0.97% | |
| HUM |
Humana Inc
Healthcare
|
NEW | 25,000 | $4,334,750 | 0.74% | |
| EHC |
Encompass Health Corp
Healthcare
|
Added | 42,000 | $4,062,660 | 0.69% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Reduced | 60,000 | $3,765,000 | 0.64% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
NEW | 215,934 | $3,452,784 | 0.59% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
NEW | 20,000 | $2,787,400 | 0.48% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
Added | 249,390 | $2,770,722 | 0.47% | |
| KPTI |
Karyopharm Therapeutics Inc.
Healthcare
|
Added | 463,741 | $2,583,037 | 0.44% | |
| CNC |
Centene Corp
Healthcare
|
Reduced | 70,000 | $2,291,800 | 0.39% | |
| MSLE |
Satellos Bioscience Inc.
Healthcare
|
NEW | 387,769 | $2,183,139 | 0.37% | |
| PODD |
Insulet Corp
Healthcare
|
NEW | 10,000 | $2,098,400 | 0.36% | |
| NTRA |
Natera, Inc.
Healthcare
|
Reduced | 9,000 | $1,799,910 | 0.31% | |
| ICLR |
Icon PLC
Healthcare
|
Reduced | 16,000 | $1,770,560 | 0.30% | |
| CRL |
Charles River Laboratories International, Inc.
Healthcare
|
NEW | 10,000 | $1,725,000 | 0.30% | |
| KVUE |
Kenvue Inc.
Consumer Defensive
|
Reduced | 100,000 | $1,724,000 | 0.29% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
NEW | 115,000 | $1,682,450 | 0.29% | |
| HIMS |
Hims & Hers Health, Inc.
Healthcare
|
NEW | 75,000 | $1,557,000 | 0.27% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
NEW | 15,000 | $1,458,750 | 0.25% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
NEW | 30,000 | $1,446,000 | 0.25% | |
| GMAB |
Genmab A/S
Healthcare
|
Reduced | 50,000 | $1,341,500 | 0.23% | |
| CORT |
Corcept Therapeutics Inc
Healthcare
|
Added | 30,000 | $1,209,300 | 0.21% | |
| TEM |
Tempus AI, Inc.
Healthcare
|
NEW | 25,000 | $1,130,500 | 0.19% | |
| ABVX |
Abivax S.A.
Healthcare
|
NEW | 10,000 | $1,113,500 | 0.19% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
NEW | 3,800 | $1,028,242 | 0.18% | |
| ABT |
Abbott Laboratories
Healthcare
|
NEW | 10,000 | $1,026,700 | 0.18% | |
| NTLA |
Intellia Therapeutics, Inc.
Healthcare
|
NEW | 75,000 | $961,500 | 0.16% | |
| ODD |
Oddity Tech Ltd
Consumer Defensive
|
NEW | 70,000 | $936,600 | 0.16% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
NEW | 50,000 | $932,000 | 0.16% | |
| PTON |
Peloton Interactive, Inc.
Consumer Cyclical
|
NEW | 200,000 | $858,000 | 0.15% | |
| AVR |
Anteris Technologies Global Corp.
Healthcare
|
NEW | 150,000 | $832,500 | 0.14% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
NEW | 10,000 | $742,600 | 0.13% | |
| ABUS |
Arbutus Biopharma Corp
Healthcare
|
NEW | 125,000 | $562,500 | 0.10% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
NEW | 43,853 | $392,484 | 0.07% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Reduced | 12,967 | $288,645 | 0.05% | |
| SVRA |
Savara Inc
Healthcare
|
NEW | 50,000 | $273,000 | 0.05% |